Email Updates2019 National Survey On Drug Use And Health: Women
These reports and detailed tables present estimates from the 2019 National Survey on Drug Use and Health (NSDUH), specifically pertaining to substance use among women.
Report/Paper/Issue Brief
PDF documents of various lengths (though usually longer than one page), which have a practical application for clinical staff or others. Most fall into the category of grey literature, which includes government reports, white papers, and issue briefs. Generally this will not include peer-reviewed journal articles. Items often have a title or description that includes one of these terms.
Substance Use and Pregnancy—Part 1: Current State Policies on Mandatory Reporting of Substance Use During Pregnancy, and Their Implications
This is the first in a series of articles on state policies that support or inhibit postpartum women’s (PPWs’) access to long-term recovery from opioid-use disorders (OUDs). It reviews current federal and state policies on mandatory reporting by health care professionals of a patient's substance use during pregnancy and their implications
A Practical Research Agenda for Treatment Development for Stimulant Use Disorder - Meeting Summary: May 2022
This document summarizes a discussion from a workshop where experts examined the evidence for candidate endpoints and study design strategies for clinical trials of stimulant use disorder treatments.
Fentanyl Drug Checking and Screening: Roundtable on Clinical Perspectives Summary Report
This document summarizes the discussion from the meeting of clinicians and researchers who are knowledgeable about screening for fentanyl and other drugs, primarily in health care settings. The focus of the meeting was to understand clinician/researcher perspectives about clinical fentanyl testing and distribution of fentanyl test strips (FTS) to patients and discuss next steps for technology development, research, and practice.
Vital Signs: Drug Overdose Deaths, by Selected Sociodemographic and Social Determinants of Health Characteristics — 25 States and the District of Columbia, 2019-2020
This report describes changes in drug overdose death rates from 2019 to 2020, stratified by sex, age group, and race and ethnicity. In addition, it examines differences in circumstances surrounding drug overdose, and assesses differences in overdose death rates by county-level income inequality and availability of mental health treatment providers and providers of medications for opioid use disorder.
Key Substance Use and Mental Health Indicators in the United States: Results from the 2020 National Survey on Drug Use and Health (NSDUH)
Based on 2020 and earlier NSDUH data, this report contains findings on a wide variety of key substance use and mental health indicators in the United States.
State-Level Economic Costs of Opioid Use Disorder and Fatal Opioid Overdose — United States, 2017
These estimated costs of opioid use disorder and fatal opioid overdose and their per capita costs at the state level can assist federal and state decision makers in understanding the magnitude of opioid use disorder and fatal opioid overdose in their jurisdictions.
Provisional Drug Overdose Death Counts
This data visualization presents provisional counts for drug overdose deaths based on a current flow of mortality data in the National Vital Statistics System.
Opioid Use in the Context of Polysubstance Use: Research Opportunities for Prevention, Treatment, and Sustained Recovery - Executive Summary
A summary of a workshop from the National Institutes of Health (NIH) HEAL (Helping to End Addiction Long-Term) Initiative, discussing opioid use in the context of polysubstance use.
Polysubstance Use Disorders in Four State Medicaid Programs
This brief examines the prevalence of diagnoses of polysubstance use disorders, describes the characteristics of Medicaid enrollees with polysubstance use disorders, and compares the mental health and medical comorbidities based on the number of unique substance use disorders.